Global Market for Biosensors is Projected to Reach US$20.7 Billion by 2020
Expanding Medical and Non-Medical Applications to
Stimulate Growth in the Global Biosensors Market, According to New Report by Global Industry Analysts, Inc.
GIA announces
the release of a comprehensive global report on Biosensors markets. Global market for Biosensors is projected
to reach US$20.7 billion by 2020, driven by the emergence of new
technologies, growing need to manage health issues such as diabetes, and robust
demand from new application areas.
A biosensor is
an analytical bioelectronic device that captures the biological signal from
analyte and translates these signals into measurable output. Given its ability
to efficiently detect analytes, biosensor finds use in a broad range of end-use
industries including medical diagnostics, general healthcare, environmental
monitoring, and food and agriculture, among others. Expanding medical and
non-medical applications, increasing investments in biosensor R&D initiatives,
and development of novel technologies are driving growth in the market. Specifically,
expanding diabetes population and the increasing emphasis on home care
diagnostics are favoring growth.
Future growth in
the market will be driven by increasing use in drug discovery, diabetes
monitoring, environmental monitoring, agriculture, and bio-defense sectors.
Technological advancements such as miniaturization and micro-fabrication are
also enabling deeper penetration of biosensors into a wider range of
application markets. Additionally, the shift towards telemetrics, growing
popularity of micro-fluidics, developments in nanotechnology, molecular
markers, surface characterization, and bio-complimentary chemistry, are all expected
to significantly impact growth in the future. Nanotechnology is expected to
play a vital role in biosensor development, owing to the unique optical,
mechanical, physical and magnetic characteristics of nanomaterials such as
graphene, carbon nanotubes, quantum dots, gold nanoparticles and nanowires.
Medical
biosensors are expected to benefit from the high prevalence of diabetes worldwide
and the ensuing focus on self-care in management of the disease. While blood
glucose meters are the most widely sold biosensors, biosensors used in areas
such as microbial, bio-molecular, and chemical detection are expected to make
strong gains in the coming years. Use of biomarkers in other medical
applications such as in oncology and cardiology is also helping lend
significant traction to growth. Non-medical applications of biosensors such as
in industrial control, environmental monitoring and bio-defense will bring in new
opportunities for growth.
As stated by
the new market research report on Biosensors,
the United States represents the largest market worldwide supported by aging
population, sophisticated healthcare infrastructure, and increasing demand for
point-of-care testing & monitoring as a result of the growing preference
for alternate care sites. Asia-Pacific ranks as the fastest growing market with
a CAGR of 13.9% over the analysis period. Growth in the region is driven by improved
access to affordable healthcare services, improvement in per capita healthcare spends
and growing healthcare awareness and focus on effective disease
management.
Key players
covered in the report include Abbott Point Of Care Inc., Animas Corporation,
Bio-Rad Laboratories Inc., GE Healthcare Life Sciences, F. Hoffmann-La Roche
Ltd, LifeScan Inc., Medtronic MiniMed Inc., Abtech Scientific Inc., Agamatrix
Inc., Cambridge Life Sciences Limited, EMD Millipore Corporation, Innovative
Biosensors Inc., I-Sens Ltd., Nova Biomedical Corp., PerkinElmer Inc., and Sigma
Aldrich Corporation, among others.
The research
report titled “Biosensors: A
Global Strategic Business Report” announced by Global Industry Analysts
Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies.
The report provides market estimates and projections in dollars for all major
geographic markets including the US, Canada, Japan, Europe (France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China and Rest of
Asia-Pacific), and Rest of World. Product Group/Segment analyzed include
Medical Biosensors (Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors, and Other Biosensors.
Comments
Post a Comment